PubRank
Search
About
A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers
Clinical Trial ID NCT00000884
PubWeight™ 1.13
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT00000884
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design.
Int Rev Immunol
2009
1.13
Next 100